HM Rando
HM Rando
### Description of the proposed additions or changes @agitter I noticed a few of the template variables aren't working still (I don't seem to have written some of them to...
Minimum path to submission: - [ ] Update with omicron - [ ] Add estimates of general evolutionary parameters - [ ] Add a bit of zoonotic context (which species...
### Description of the proposed additions or changes ### Related issues ### Suggested reviewers (optional) ### Checklist - [ ] Text is formatted so that each sentence is on its...
Title: Genetic risk for severe COVID-19 correlates with lower inflammatory marker levels in a SARS-CoV-2-negative cohort # General Information ## Please paste a link to the paper or a citation...
Title: Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine # General Information ## Please paste a link to the paper or a citation...
The terminology in the [vaccines summary figure](https://github.com/greenelab/covid19-review/blob/master/content/images/N002-Vaccines.png) doesn't quite agree with the terminology we use in the paper. Currently the way the paper is structured is: 1. Whole-Virus Vaccines -...
Two new therapeutics that should be added to the pharmaceuticals manuscript: - MAb from AstraZeneca: https://www.astrazeneca.com/media-centre/press-releases/2021/azd7442-prophylaxis-trial-met-primary-endpoint.html - Antiviral from Merck: https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/
In this study, the authors surveyed a large number of surfaces to see if they could amplify evidence of human and SARS-CoV-2 genomes. They found lots of evidence of humans,...
May want to look into this when going through evolution section
May want to consider adding to evolution depending on how the literature looks